DE69822542D1 - Verkapslung einer Untereinheit des Bovinen Herpes Virus Typ-1 in wässrigen Lösungsmitteln als Impfstoff. - Google Patents

Verkapslung einer Untereinheit des Bovinen Herpes Virus Typ-1 in wässrigen Lösungsmitteln als Impfstoff.

Info

Publication number: DE69822542D1
Authority: DE; Germany
Prior art keywords: vaccine; subunit; encapsulation; virus type; herpes virus
Prior art date: 1997-04-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69822542T

Other languages

English (en)

Other versions

DE69822542T2 (de

Inventor

Manuel Campos

Patrick Frenchick

Frederick Clark

Paul Offit

Charlotte Moser

Tully Speaker

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Corp Belgium

Childrens Hospital of Philadelphia CHOP

Pfizer Inc

Temple Univ School of Medicine

Original Assignee

Pfizer Corp Belgium

Childrens Hospital of Philadelphia CHOP

Pfizer Inc

Temple Univ School of Medicine

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-23

Filing date

1998-04-14

Publication date

2004-04-29

1998-04-14 Application filed by Pfizer Corp Belgium, Childrens Hospital of Philadelphia CHOP, Pfizer Inc, Temple Univ School of Medicine filed Critical Pfizer Corp Belgium

2004-04-29 Publication of DE69822542D1 publication Critical patent/DE69822542D1/de

2004-08-05 Application granted granted Critical

2004-08-05 Publication of DE69822542T2 publication Critical patent/DE69822542T2/de

2018-04-15 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/813—Viral vaccine for bovine species, e.g. cattle

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

DE1998622542 1997-04-23 1998-04-14 Verkapslung einer Untereinheit des Bovinen Herpes Virus Typ-1 in wässrigen Lösungsmitteln als Impfstoff. Expired - Fee Related DE69822542T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4417297P	1997-04-23	1997-04-23
US44172P		1997-04-23

Publications (2)

Publication Number	Publication Date
DE69822542D1 true DE69822542D1 (de)	2004-04-29
DE69822542T2 DE69822542T2 (de)	2004-08-05

Family

ID=21930892

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE1998622542 Expired - Fee Related DE69822542T2 (de)	1997-04-23	1998-04-14	Verkapslung einer Untereinheit des Bovinen Herpes Virus Typ-1 in wässrigen Lösungsmitteln als Impfstoff.

Country Status (15)

Country	Link
US (1)	US6270800B1 (de)
EP (1)	EP0873752B1 (de)
JP (1)	JPH10316586A (de)
CN (1)	CN1196931A (de)
AR (1)	AR012009A1 (de)
AT (1)	ATE262324T1 (de)
AU (1)	AU713639B2 (de)
BR (1)	BR9801435A (de)
CA (1)	CA2229430A1 (de)
DE (1)	DE69822542T2 (de)
DK (1)	DK0873752T3 (de)
ES (1)	ES2216242T3 (de)
NZ (1)	NZ330251A (de)
PT (1)	PT873752E (de)
ZA (1)	ZA983327B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6855316B1 (en) *	1994-02-14	2005-02-15	University Of Hawaii	Baculovirus produced Plasmodium falciparum vaccine
WO2000045847A1 (en) *	1999-02-05	2000-08-10	Alk-Abelló A/S	Novel mucosal delivery system
KR20010003853A (ko) *	1999-06-25	2001-01-15	박호군	경구용 백신으로 사용할 수 있는 알긴산염 마이크로스피어 및그 제조방법
US7037681B2 (en) *	2000-02-08	2006-05-02	University Of Hawaii	Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants
US20030100106A1 (en) *	2000-02-08	2003-05-29	Chang Sandra P.	Baculovirus produced Plasmodium falciparum vaccine
JP4370451B2 (ja) *	2001-09-28	2009-11-25	大塚製薬株式会社	医薬組成物
US8039015B2 (en) *	2004-12-08	2011-10-18	Speaker Tycho J	Microencapsulation product and process
CN104302279A (zh) *	2012-05-10	2015-01-21	聚和国际股份有限公司	用于制备微胶囊的组合物及用其所制得的药物
WO2014193908A1 (en)	2013-05-28	2014-12-04	Capsulent	Products containing charged polymer complex microcapsules and method of use
CN107973840A (zh) *	2017-01-13	2018-05-01	浙江海隆生物科技有限公司	CHO细胞表达牛传染性病气管炎病毒gD蛋白及其亚单位疫苗的制备和应用
CN112180089A (zh) *	2020-09-21	2021-01-05	黑龙江八一农垦大学	一种牛疱疹病毒i型抗体阻断elisa检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5585264A (en) *	1988-07-15	1996-12-17	University Of Saskatchewan	Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides
US5151267A (en) *	1988-07-15	1992-09-29	University Of Saskatchewan	Bovine herpesvirus type 1 polypeptides and vaccines
US5462734A (en) *	1990-11-02	1995-10-31	Wisconsin Alumni Research Foundation	Bovine herpesvirus vaccine and method of using same
ATE235959T1 (de) *	1994-04-15	2003-04-15	Univ Temple	Methode zum einkapseln mittels eines wässrigen lösungsmittels und mikrokapseln
US5686113A (en) *	1995-03-21	1997-11-11	Temple University Of The Commonwealth System Of Higher Education	Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses

1998
- 1998-04-14 PT PT98302863T patent/PT873752E/pt unknown
- 1998-04-14 EP EP19980302863 patent/EP0873752B1/de not_active Expired - Lifetime
- 1998-04-14 ES ES98302863T patent/ES2216242T3/es not_active Expired - Lifetime
- 1998-04-14 DE DE1998622542 patent/DE69822542T2/de not_active Expired - Fee Related
- 1998-04-14 DK DK98302863T patent/DK0873752T3/da active
- 1998-04-14 AT AT98302863T patent/ATE262324T1/de not_active IP Right Cessation
- 1998-04-21 ZA ZA9803327A patent/ZA983327B/xx unknown
- 1998-04-21 US US09/063,676 patent/US6270800B1/en not_active Expired - Lifetime
- 1998-04-21 AU AU63511/98A patent/AU713639B2/en not_active Ceased
- 1998-04-22 CN CN98107316A patent/CN1196931A/zh active Pending
- 1998-04-22 NZ NZ330251A patent/NZ330251A/en unknown
- 1998-04-22 AR ARP980101867 patent/AR012009A1/es not_active Application Discontinuation
- 1998-04-23 CA CA 2229430 patent/CA2229430A1/en not_active Abandoned
- 1998-04-23 BR BR9801435A patent/BR9801435A/pt not_active IP Right Cessation
- 1998-04-23 JP JP11392798A patent/JPH10316586A/ja active Pending

Also Published As

Publication number	Publication date
AU6351198A (en)	1998-11-12
NZ330251A (en)	1998-11-25
ATE262324T1 (de)	2004-04-15
US6270800B1 (en)	2001-08-07
AR012009A1 (es)	2000-09-13
EP0873752A2 (de)	1998-10-28
EP0873752A3 (de)	2001-02-07
PT873752E (pt)	2004-07-30
ZA983327B (en)	1999-10-21
DE69822542T2 (de)	2004-08-05
AU713639B2 (en)	1999-12-09
EP0873752B1 (de)	2004-03-24
DK0873752T3 (da)	2004-05-10
CN1196931A (zh)	1998-10-28
ES2216242T3 (es)	2004-10-16
BR9801435A (pt)	2000-01-11
CA2229430A1 (en)	1998-10-23
JPH10316586A (ja)	1998-12-02

Publication	Publication Date	Title
DZ2462A1 (fr)	2003-01-18	Vaccin antigrippal.
NO20000257D0 (no)	2000-01-19	Modifisert immunogent pneumolysin, sammensetninger omfattende dette samt anvendelse derav som vaksine
NO986208D0 (no)	1998-12-30	Vandige peptidformuleringer
DE69835557D1 (de)	2006-09-28	Wässrige Tintenzusammensetzungen
NO20003303D0 (no)	2000-06-23	Vaksine
EP0621339A3 (en)	1995-11-29	Immunogenic human influenza a virus haemagglutinin polypeptides.
NO911401D0 (no)	1991-04-10	Konsentrerte, vandige overflateaktive midler.
DE69420357D1 (de)	1999-10-07	Wässrige, alkalische Zubereitung
DE69001730D1 (de)	1993-07-01	Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
NO996133D0 (no)	1999-12-10	Olje-i-vann-vaksinesammensetninger
DK0769965T3 (da)	2002-02-04	Vandige risperidonformuleringer
FI970277L (fi)	1997-01-23	Influenssavirusalayksikön konjugaatteja
DZ1706A1 (fr)	2002-02-17	Vaccin contre le virus de l'hepatite a.
DE69822542D1 (de)	2004-04-29	Verkapslung einer Untereinheit des Bovinen Herpes Virus Typ-1 in wässrigen Lösungsmitteln als Impfstoff.
DE59004585D1 (de)	1994-03-24	Hochkonzentrierte feste Pigmentpräparationen.
EP0366238A3 (de)	1990-07-25	Influenzavakzin-Polypeptide
IS2797B (is)	2012-08-15	Bóluefni gegn ISA-veiru
MX9206973A (es)	1993-06-01	Vacuna a base de virus del herpes bovino modificado tipo 1.
ZA984696B (en)	1999-01-04	Vaccine compositions V.
BR1100968A (pt)	2002-04-09	Formulação de vacina de subunidade
GB9703202D0 (en)	1997-04-02	HIV vaccine
GB9725241D0 (en)	1998-01-28	Hiv vaccine
BRPI9915352A2 (pt)	2017-11-14	micro usina virtual (m.u.v)
ES1038368Y (es)	1999-01-01	Sobre reutilizable perfeccionado.
ES1037044Y (es)	1998-05-01	Sobre perfeccionado.

Legal Events

Date	Code	Title	Description
2005-04-21	8364	No opposition during term of opposition
2008-02-14	8339	Ceased/non-payment of the annual fee